Reference scope and decision rule
This reference compares cosmetic products placed on the market in Great Britain, meaning England, Scotland and Wales, with products placed on the market in the European Union. It focuses on ingredient prohibitions, restrictions and ingredient-related labelling requirements that may differ because EU legal amendments made after the end of the transition period do not automatically amend Great Britain law. Northern Ireland requires a separate assessment. EU cosmetics rules remain relevant to products placed on the Northern Ireland market under the Windsor Framework arrangements.
The legal texts began from a closely related position. The EU applies Regulation (EC) No 1223/2009 on cosmetic products, as amended. Great Britain applies the assimilated Cosmetic Products Regulation within its domestic framework. A common original text does not establish that the current annexes, schedules, transition periods or related chemical restrictions remain the same. The relevant question is what applied when the product was first placed on the particular market.
Six-pass dual-market decision rule: identify the product type; identify every restricted substance and relevant fragrance constituent; compare the current EU and GB annex entries; check related EU REACH and UK REACH controls; apply the relevant market's transition date; then update the product information file, notification and pack for that market. An EU scientific opinion, draft measure or classification change is not itself a GB cosmetics rule. Equally, an EU legal amendment is not proof that the equivalent GB text has changed.
| Question | Decision |
|---|---|
| Has the EU changed a cosmetics annex after the transition period? | Check whether a separate GB statutory instrument changed the corresponding GB annex or schedule. |
| Is the ingredient also controlled under REACH? | Review the relevant EU REACH or UK REACH restriction alongside cosmetics legislation. |
| Do the rules differ? | Maintain separate compliance conclusions, packs where needed, and controlled product records. |
| Is the product sold in Northern Ireland? | Assess the Northern Ireland route separately rather than treating it as part of the GB route. |
This approach avoids a frequent error: treating a shared ingredient list as evidence of shared legal status. The formula, product form, intended function, particle properties, concentration and first-placement date can all affect the result.
Confirmed divergence: synthetic polymer microparticles
The clearest current restriction difference concerns synthetic polymer microparticles, often described as the EU microplastics restriction. The European Commission introduced the restriction through Commission Regulation (EU) 2023/2055, which amended Annex XVII to EU REACH. The regulation entered into force on 17 October 2023. It is not an amendment to the EU Cosmetics Regulation itself, but it can determine whether a cosmetic ingredient or finished product may be placed on the EU market.
The restriction covers synthetic polymer microparticles as legally defined, subject to detailed scope provisions, exclusions and exemptions. It is not a prohibition on every polymer, every liquid polymer or every material described in ordinary language as plastic. For cosmetics, the EU measure includes transition arrangements that vary according to the product category and use. A legal assessment therefore needs to establish the material's polymer identity, particle characteristics, intended function, product type and the applicable transition provision.
Great Britain has its own UK REACH framework. The EU restriction made through Commission Regulation (EU) 2023/2055 did not automatically become a UK REACH restriction or a GB cosmetics restriction. In the absence of an equivalent GB legal amendment, EU compliance under this measure cannot establish that a material is prohibited in GB. The reverse is also true: GB placement does not remove the obligation to comply with the EU restriction when the product is placed on an EU market.
| Item | EU position | GB point to check | Authority and date |
|---|---|---|---|
| Synthetic polymer microparticles | Restricted under EU REACH Annex XVII, with defined exemptions and product-specific transition periods. | The EU amendment does not itself alter UK REACH or the GB cosmetic rules. | European Commission, Commission Regulation (EU) 2023/2055, 25 September 2023; in force from 17 October 2023. |
The appropriate evidence is technical rather than promotional: supplier specifications, compositional information, particle evidence, rationale for any exemption, product category and the date of first placement on each market. A broad statement that a material is microplastic-free does not, on its own, resolve the legal definition.
Confirmed divergence: expanded EU fragrance-allergen disclosure
The European Commission expanded EU fragrance-allergen labelling requirements through Commission Regulation (EU) 2023/1545. The measure added a substantial group of fragrance allergens to the individual ingredient disclosure system in the EU Cosmetics Regulation and revised related entries. It was made on 26 July 2023. Its transition provisions distinguish between products newly placed on the EU market and products already placed there.
This change is principally a labelling divergence rather than a universal prohibition on the substances concerned. Where an allergen is present above the applicable threshold in the finished cosmetic product, the relevant name may need to appear in the EU ingredient list. A formula can remain physically unchanged while its EU artwork, ingredient-list governance and pack approval process need revision. An International Nomenclature of Cosmetic Ingredients list should not be treated as a single generic text for all territories once local disclosure requirements differ.
Great Britain's inherited allergen disclosure provisions did not automatically expand when the EU measure was made. A GB label should be assessed against the current GB schedules rather than altered solely because of the EU amendment. A combined pack may contain information beyond one market's minimum requirement, but it must remain accurate, legible and consistent with mandatory particulars. The Responsible Person should retain a documented explanation of why the selected ingredient list is lawful in each market.
| Item | EU position | GB consequence | Authority and date |
|---|---|---|---|
| Expanded fragrance-allergen list | Additional allergen disclosures are introduced, subject to thresholds and phased deadlines. | No matching GB change follows automatically from the EU regulation. Check the current GB entry. | European Commission, Commission Regulation (EU) 2023/1545, 26 July 2023. |
| New EU products | The main EU compliance date is 31 July 2026. | This is not, by itself, a GB deadline. | European Commission, Commission Regulation (EU) 2023/1545. |
| EU products already placed on the market | The main EU sell-through deadline is 31 July 2028. | Do not assume the EU sell-through provision applies in GB. | European Commission, Commission Regulation (EU) 2023/1545. |
The practical implication is to control formula and artwork changes together. The formula review should establish concentration and threshold relevance, while the artwork review should establish the correct ingredient expression for the destination market.
CMR classifications and why classification alone is not enough
Cosmetics law includes a structured framework for substances classified as carcinogenic, mutagenic or toxic to reproduction, generally shortened to CMR. Under Article 15 of the EU Cosmetics Regulation, CMR substances are subject to a prohibition and exception framework. Changes under the EU Classification, Labelling and Packaging regime may therefore have consequences for cosmetic products, but a classification measure, a scientific opinion and an entry in a cosmetics annex perform different legal functions.
Following Brexit, EU classification changes do not automatically amend the GB classification regime. Nor do they automatically amend GB cosmetic schedules. For a substance with potential CMR relevance, the review should establish its identity and synonyms, its current EU classification, its current GB classification, and the current EU and GB cosmetics entries. The name on a safety data sheet, the International Nomenclature of Cosmetic Ingredients name and the name in a legal annex may differ. Matching those names is an identity exercise, not a simple text search.
A short static list claiming to capture every CMR-related divergence would soon become unreliable. The European Commission, the Health and Safety Executive and the Office for Product Safety and Standards have roles in different legal systems and for different regulatory purposes. The body associated with a classification development may not be the body that makes a cosmetics-specific amendment.
Decision rule: where an EU CMR classification or cosmetics restriction changes, identify the exact legal act, its application date and any transitional provision. Then locate the equivalent GB statutory instrument or establish that no corresponding amendment has changed the GB text. Record the conclusion using the Chemical Abstracts Service number where available, while retaining the legal name used in the relevant annex. A formula should not be described as compliant in both markets on the basis of one jurisdiction's review alone.
Records and notification routes for dual-market supply
Separate market routes create separate recordkeeping obligations even where the formulation is identical. For EU placement, a product requires an EU Responsible Person and a product information file kept readily accessible at that Responsible Person's address. Notification is made through the Cosmetic Products Notification Portal. For Great Britain, the product requires a UK Responsible Person, a product information file available at that Responsible Person's address, and notification through the Submit Cosmetic Product Notifications service.
The cosmetic product safety report is not simply a historic approval document. It must support the formula, impurities, exposure assumptions, packaging interaction where relevant, warnings, manufacturing method and legal compliance position in the market concerned. If an ingredient position differs between markets, the safety assessment conclusion, product information file index, notification data and final pack may all require controlled revision. The EU Responsible Person and UK Responsible Person may be different legal persons, making clear version control important.
| Record or role | EU market | Great Britain market |
|---|---|---|
| Responsible Person | An EU-based Responsible Person holds the accessible product information file. | A UK-based Responsible Person holds the accessible product information file. |
| Pre-market notification | Cosmetic Products Notification Portal. | Submit Cosmetic Product Notifications service. |
| Ingredient legal review | Current EU Cosmetics Regulation annexes and applicable EU chemical restrictions. | Current GB cosmetic schedules and applicable UK chemical restrictions. |
| Pack control | Assess EU disclosures, language and mandatory particulars for the destination state. | Assess mandatory particulars against the GB rules. |
| Change evidence | Retain evidence for formula, label and notification updates in the EU file. | Retain evidence for formula, label and notification updates in the GB file. |
The Office for Product Safety and Standards oversees the GB cosmetics framework. The European Commission maintains the EU framework, while national competent authorities enforce it within EU states. Notification through either route does not certify that a product is compliant.
How to maintain a comparison without false certainty
A maintained comparison needs a defined boundary. This reference identifies confirmed, high-value post-Brexit differences and sets out a review method. It is not a line-by-line audit of every annex entry, and it does not turn future proposals into present obligations. Ingredient controls can change through cosmetics annex amendments, chemical restrictions, classification measures and market-specific transition provisions.
Begin each review cycle with the controlled formula inventory rather than the front-label ingredient list. Retain supplier declarations, specifications, impurity information and the date on which each statement was obtained. Review the EU consolidated Cosmetics Regulation and EU REACH status. Then review the GB consolidated cosmetic text, relevant GB statutory instruments and UK REACH status. Record each result as matched, EU-only change, GB-only change, or unresolved pending identity evidence or legal interpretation.
Each conclusion should have an accountable role. Regulatory affairs should approve legal-status mapping; the safety assessor should consider safety implications; artwork control should approve the ingredient list and warnings; and the Responsible Person should approve market placement. This records who made each decision and prevents a supplier email from being treated as definitive legal evidence.
Keep the legal act's publication date, application date, transition end date and internal review date in distinct fields. A rule can be published but not yet applicable. A product may be supplied under a sell-through provision while newly placed stock cannot be. Those distinctions matter for inventory, relabelling, reformulation and supply to distributors in more than one territory.
Limits of this reference
This reference does not cover cosmetic procedures, medicines, medical devices, biocides, food supplements, occupational chemical requirements beyond their relevance to placing a cosmetic product on the market, tax or customs. It does not decide whether a particular material meets the legal definition of a synthetic polymer microparticle, whether a fragrance constituent exceeds a disclosure threshold, or whether a CMR exception is available. Those questions depend on substance identity, concentration, exposure, product form and the exact current legal text.
It does not apply the GB route to Northern Ireland. A business placing a product on the Northern Ireland market needs to consider the applicable Northern Ireland position separately. It also does not set out every national language requirement or enforcement practice within individual EU states. The core EU rule may be shared, while label language and local market arrangements can still differ.
Finally, this is not a claim that every EU and GB ingredient rule has diverged. Many provisions remain aligned, including where Great Britain has made its own amendments. The narrower conclusion is that a post-Brexit EU amendment is a reason to compare the two regimes, not evidence that Great Britain has made the same change. Where a conclusion could affect launch, relabelling, withdrawal or a safety assessment, the relevant live legislation and product documentation should be checked before action is taken.
Questions readers ask
Does an EU cosmetics rule automatically apply in Great Britain?
No. Great Britain retained an EU-derived cosmetics framework, but EU amendments made after the end of the transition period do not automatically amend GB law. Check the current GB schedules and any relevant GB statutory instrument. A shared original regulation is not enough to show that the current legal requirements are aligned.
Do EU microplastics rules apply to cosmetic products sold in GB?
The EU restriction on synthetic polymer microparticles under Commission Regulation (EU) 2023/2055 applies within the EU legal framework. It did not automatically become a UK REACH restriction. A product supplied in both places requires separate checks of the EU restriction, UK REACH status and any applicable cosmetics requirements.
When do the expanded EU fragrance-allergen labelling rules apply?
Commission Regulation (EU) 2023/1545 provides for a main compliance date of 31 July 2026 for newly placed EU products and 31 July 2028 for products already placed on the EU market. The applicability of the disclosure requirement still depends on the relevant allergen, finished-product concentration and legal threshold.
Can one ingredient list be used for both EU and GB packs?
It may be possible in some cases, but it should not be assumed. The EU's expanded fragrance-allergen disclosure requirements do not automatically apply in Great Britain. A combined list must remain accurate, legible and compliant with the mandatory particulars for each destination market, including any applicable language requirements.
Is an EU CMR classification enough to prohibit a cosmetic ingredient in GB?
No. An EU classification development, an EU cosmetics-annex amendment and a GB legal change are separate matters. Review the substance identity, current EU and GB classification positions, and the relevant EU and GB cosmetics entries. Confirm whether a corresponding GB instrument has changed the domestic legal text.
Does notification through the EU or GB portal prove compliance?
No. Notification is a market-access requirement, not a compliance certificate. The Responsible Person remains responsible for ensuring that the product information file, safety report, formula, label and other required material support lawful placement on the relevant market. Separate EU and GB notification records may be needed.
Does this comparison apply to Northern Ireland?
No. Northern Ireland should not be treated as part of the standard Great Britain route in this comparison. Products placed on the Northern Ireland market require consideration of the applicable Northern Ireland arrangements, including the continuing relevance of EU cosmetics rules under the Windsor Framework.
What should be retained for a microplastics restriction assessment?
Keep material specifications, supplier information, particle and polymer evidence where relevant, the product category, the legal rationale for any exemption, and the date the product was first placed on each market. A broad supplier statement alone may not resolve whether a material falls within the legal definition or a transition provision.